Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

$CYTKPress releaseApr 28, 2026, 7:30 AM ETRead the release

Cytokinetics announced nine presentations at the ESC Heart Failure 2026 Congress, including a late-breaking science oral presentation on MYQORZO (aficamten). The presentations cover analyses from the MAPLE-HCM, SEQUOIA-HCM, FOREST-HCM, and GALACTIC-HF trials, focusing on clinical outcomes and economic burden in HCM and heart failure.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.